Mendelian randomization analysis identified tumor necrosis factor as being associated with severe COVID-19
Background: Observational studies have shown that anti-tumor necrosis factor (TNF) therapy may be beneficial for patients with coronavirus disease 2019 (COVID-19). Nevertheless, because of the methodological restrictions of traditional observational studies, it is a challenge to make causal inferenc...
Saved in:
Main Authors: | Hongfei Song (Author), Na Lei (Author), Ling Zeng (Author), Xiuyan Li (Author), Cen Jiang (Author), Quansheng Feng (Author), Yue Su (Author), Jibin Liu (Author), Jie Mu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetically proxied inhibition of tumor necrosis factor and the risk of colorectal cancer: A drug-target mendelian randomization study
by: Min Chen, et al.
Published: (2022) -
TNFPred: identifying tumor necrosis factors using hybrid features based on word embeddings
by: Trinh-, et al.
Published: (2020) -
Systematic druggable genome‐wide Mendelian randomization identifies therapeutic targets for sarcopenia
by: Kang‐Fu Yin, et al.
Published: (2024) -
Adverse events of tumor necrosis factor alpha inhibitors for the treatment of ankylosing spondylitis: A meta-analysis of randomized, placebo-controlled trials
by: Haihuan Feng, et al.
Published: (2023) -
Gut microbes combined with metabolomics reveal the protective effects of Qijia Rougan decoction against CCl4-induced hepatic fibrosis
by: Xue Li, et al.
Published: (2024)